Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 4:04 AM
Ignite Modification Date:
2025-12-25 @ 4:04 AM
NCT ID:
NCT07153302
Eligibility Criteria:
Inclusion Criteria:
1. Patients of 18 to 55 years of age of any gender.
2. Agree and able to voluntary participate.
3. Patients with trauma associated femur fracture and tibia shaft fracture arriving at hospital for treatment.
Exclusion Criteria:
1. Mentally retarded or patients with severe psychiatric illness.
2. Patients are already on bone-strengthening drugs (bisphosphonates, vitamin D, strontium ranelate, teriparatide, etc.).
3. Patients who require bone-strengthening drugs for osteoporosis or for any urgent need.
4. Severe cardiovascular, hepatic, or renal disease.
5. Known allergy or toxicity to Prunus dulcis (almonds) and/or vitamin D supplements.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
55 Years
Study:
NCT07153302
Study Brief:
Protocol Section:
NCT07153302